| abstract |
Compound of the general formula: (I) (wherein all the symbols have the same meaning as in the description). This compound exhibits antagonism against cysLT2 receptor, so that it is useful as, for example, a preventive and/or therapeutic agent for respiratory diseases (for example, bronchial asthma, chronic obstructive lung disease, pulmonary emphysema, chronic bronchitis, pneumonia (e.g., interstitial myositis, etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g., acute sinusitis, chronic sinusitis, etc.), etc.), or as an expectorant agent or cough suppressant. |